Tomer Kariv, Director at VBI Vaccines Inc/BC (VBIV), bought 2,857,142 shares at $1.40 ($4.0M) on 2018-12-17, disclosed to the SEC on 2018-12-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.40 | 185,714 | $260K | 6.5% |
| 2 | $1.40 | 185,714 | $260K | 6.5% |
| 3 | $1.40 | 298,431 | $418K | 10.4% |
| 4 | $1.40 | 298,431 | $418K | 10.4% |
| 5 | $1.40 | 331,429 | $464K | 11.6% |
| 6 | $1.40 | 331,429 |
| $464K |
| 11.6% |
| 7 | $1.40 | 612,997 | $858K | 21.5% |
| 8 | $1.40 | 612,997 | $858K | 21.5% |
| Total | $1.40 avg | 2,857,142 | $4.0M | 100% |
| Filing → |
| ELOX | BUY | 2019-06-26 | $1.8M | — | Filing → |
| LOGC | BUY | 2018-10-25 | $4.2M | — | Filing → |
| ELOX | BUY | 2018-05-01 | $6.8M | — | Filing → |